IRAGE as a novel carboxymethylated peptide that prevents advanced glycation end product-induced apoptosis and endoplasmic reticulum stress in vascular smooth muscle cells

Pharmacological Research

Volumn 104, Issue , 2016, Pages 176-185

  Maltais, Jean Sébastien ^a   Simard, Elie ^a   Froehlich, Ulrike ^a   Denault, Jean Bernard ^a   Gendron, Louis ^a   Grandbois, Michel ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Apoptosis; Diabetes; ER stress; Glycation; NF B; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ADVANCED GLYCATION END PRODUCT RECEPTOR ANTAGONIST; CASPASE 9; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; CASPASE 3; CASPASE 7; LYSINE; N(6)-CARBOXYMETHYLLYSINE; PEPTIDE; SERUM ALBUMIN;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME REGULATION; GLYCATION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN CLEAVAGE; RAT; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; METABOLISM; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 7; CELL LINE; ENDOPLASMIC RETICULUM STRESS; GLYCOSYLATION END PRODUCTS, ADVANCED; LYSINE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PEPTIDES; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; SERUM ALBUMIN;

EID: 84954304579     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.12.015     Document Type: Article

References (89)

1. M. Peppa, J. Uribarri, and H. Vlassara Glucose, advanced glycation end products, and diabetes complications: what is new and what works Clin. Diabetes 21 4 2003 186 187 10.2337/diaclin.21.4.186
2. L.G. Bucciarelli, T. Wendt, L. Rong, and et al. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease Cell Mol. Life Sci. 59 7 2002 1117 1128
3. G.P. Sims, D.C. Rowe, S.T. Rietdijk, R. Herbst, and A.J. Coyle HMGB1 and RAGE in inflammation and cancer Annu. Rev. Immunol. 28 2010 367 388 10.1146/annurev.immunol.021908.132603
4. A. Goldin, J.A. Beckman, A.M. Schmidt, and M.A. Creager Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 114 6 2006 597 605 10.1161/circulationaha.106.621854
5. M. Alikhani, C.M. Maclellan, M. Raptis, S. Vora, P.C. Trackman, and D.T. Graves Advance d glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor Am. J. Physiol. Cell Physiol. 292 2 2007 C850 C856
6. K. Kierdorf, and G. Fritz RAGE regulation and signaling in inflammation and beyond J. Leukoc. Biol. 94 1 2013 55 68 10.1189/jlb.1012519
7. N. Tanji, G.S. Markowitz, C. Fu, and et al. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease J. Am. Soc. Nephrol. 11 9 2000 1656 1666
8. H. Ma, S.-Y. Li, P. Xu, and et al. Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy J. Cell Mol. Med. 13 2009 1751 1764 10.1111/j.1582-4934.2008.00547.x
9. A. Bierhaus, P.M. Humpert, M. Morcos, and et al. Understanding RAGE, the receptor for advanced glycation end products J. Mol. Med. (Berl.) 83 11 2005 876 886 10.1007/s00109-005-0688-7
10. A. Bierhaus, S. Schiekofer, M. Schwaninger, and et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-B Diabetes 50 12 2001 2792 2808
11. E. Simard, T. Söllradl, J.-S. Maltais, J. Boucher, P. D'Orléans-Juste, and M. Grandbois Receptor for advanced glycation end-products signaling interferes with the vascular smooth muscle cell contractile phenotype and function T. Abraham, PLoS One 10 8 2015 e0128881 10.1371/journal.pone.0128881
12. M. Alikhani, S. Roy, and D.T. Graves FOXO1 plays an essential role in apoptosis of retinal pericytes Mol. Vis. 16 2010 408 415
13. J. Kim, C.-S. Kim, E. Sohn, Y.M. Lee, K. Jo, and J.S. Kim KIOM-79 protects AGE-induced retinal pericyte apoptosis via inhibition of NF-kappaB activation in vitro and in vivo PLoS One 7 8 2012 e43591 10.1371/journal.pone.0043591
14. L. Shi, X. Yu, H. Yang, and X. Wu Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p3 MAPK pathways PLoS One 8 6 2013 e66781 10.1371/journal.pone.0066781
15. P.Y. Chuang, Q. Yu, W. Fang, J. Uribarri, and J.C. He Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor Kidney Int. 72 8 2007 965 976 10.1038/sj.ki.5002456
16. S. Yamagishi, Y. Inagaki, T. Okamoto, and et al. Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells J. Biol. Chem. 277 23 2002 20309 20315 10.1074/jbc.m202634200
17. Z. Alikhani, M. Alikhani, C.M. Boyd, K. Nagao, P.C. Trackman, and D.T. Graves Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways J. Biol. Chem. 280 13 2005 12087 12095 10.1074/jbc.m406313200
18. D.T. Graves, R. Liu, M. Alikhani, H. Al-Mashat, and P.C. Trackman Diabetes-enhanced Inflammation and apoptosis-impact on periodontal pathology J. Dent. Res. 85 1 2006 15 21 10.1177/154405910608500103
19. M. Alikhani, Z. Alikhani, C. Boyd, and et al. Advance d glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways Bone 40 2 2007 345 353 10.1016/j.bone.2006.09.011
20. D.X. Li, T.Z. Deng, J. Lv, and J. Ke Advanced glycation end products (AGEs) and their receptor (RAGE) induce apoptosis of periodontal ligament fibroblasts Braz. J. Med. Biol. Res. 47 12 2014 1036 1043
21. E. Weinberg, T. Maymon, and M. Weinreb AGEs induce caspase-mediated apoptosis of rat BMSCs via TNFα production and oxidative stress J Mol Endocrinol. 52 1 2014 67 76 10.1530/JME 13-0229
22. Y. Zhan, H. Sun, H. Chen, and et al. Glucagon-like peptide-1 (GLP-1) protects vascular endothelial cells against advanced glycation end products (AGEs)-induced apoptosis Med. Sci. Monit. 18 7 2012 BR286 91
23. Y.J. Zhou, J.H. Wang, and J. Zhang Hepatocyte growth factor protects human endothelial cells against advanced glycation end products-induced apoptosis Biochem. Biophys. Res. Commun. 344 2 2006 658 666 10.1016/j.bbrc.2006.03.167
24. K.-C. Lan, C.-Y. Chiu, C.-W. Kao, and et al. Advanced glycation end-products induce apoptosis in pancreatic islet endothelial cells via NF-(B-activated cyclooxygenase-2/prostaglandin E2 up-regulation PLoS One 10 4 2015 e0124418 10.1371/journal.pone.0124418
25. A.P. Burke, F.D. Kolodgie, A. Zieske, and et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study Arterioscler Thromb. Vasc. Biol. 24 7 2004 1266 1271 10.1161/01.atv.0000131783.74034.97
26. R. Marfella, C. Di Filippo, A. Baldi, and et al. The vascular smooth muscle cells apoptosis in asymptomatic diabetic carotid plaques: role of glycemic control J. Am. Coll. Cardiol. 47 10 2006 2118 2120 10.1016/j.jacc.2006.02.025
27. Z. Rasheed, and T.M. Haqqi Endoplasmic reticulum stress induces the expression of COX-2 through activation of eIF2α, p38-MAPK and NF-κB in advanced glycation end products stimulated human chondrocytes Biochim. Biophys. Acta 1823 12 2012 2179 2189 10.1016/j.bbamcr.2012.08.021
28. J. Liu, K. Huang, G.-Y. Cai, and et al. Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling Cell Signal. 26 1 2014 110 121 10.1016/j.cellsig.2013.10.002
29. C. Adamopoulos, E. Farmaki, E. Spilioti, H. Kiaris, C. Piperi, and A.G. Papavassiliou Advanced glycation end-products induce endoplasmic reticulum stress in human aortic endothelial cells Clin. Chem. Lab. Med. 52 1 2014 151 160 10.1515/cclm-2012-0826
30. C. Von Roretz, X.J. Lian, A.M. Macri, and et al. Apoptotic-induced cleavage shifts HuR from being a promoter of survival to an activator of caspase-mediated apoptosis Cell Death Differ. 20 1 2013 154 168 10.1038/cdd.2012.111
31. R. Mazroui, M. Di, S. arco, E. Clair, and et al. Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis J. Cell Biol. 180 1 2008 113 127 10.1083/jcb.200709030
32. O. Drouin, HuR protein post-transcriptionally regulates pro- and anti-apoptotic messages during stress-induced cell death. 2008.
33. C. Von Roretz, HuR and its cleavage are key regulators of apoptotic cell death. 2012.
34. J. Xue, V. Rai, D. Singer, and et al. Advanced glycation end product recognition by the receptor for AGEs Structure 19 5 2011 722 732 10.1016/j.str.2011.02.013
35. L.J. Sparvero, D. Asafu-Adjei, R. Kang, and et al. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation J. Transl. Med. 7 2009 17 10.1186/1479-5876-7-17
36. H. Park, F.G. Adsit, and J.C. Boyington The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding J. Biol. Chem. 285 52 2010 40762 40770 10.1074/jbc.M110.169276
37. J. Xie, S. Reverdatto, A. Frolov, R. Hoffmann, D.S. Burz, and A. Shekhtman Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE) J. Biol. Chem. 283 40 2008 27255 27269 10.1074/jbc.m801622200
38. G. Fritz RAGE: a single receptor fits multiple ligands Trends Biochem. Sci. 36 12 2011 625 632 10.1016/j.tibs.2011.08.008
39. R. Deane, I. Singh, A.P. Sagare, and et al. A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease J. Clin. Invest. 122 4 2012 1377 1392 10.1172/JCI58642
40. H.J. Huttunen, C. Fages, J. Kuja-Panula, A.J. Ridley, and H. Rauvala Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis Cancer Res. 62 16 2002 4805 4811
41. T. Arumugam, V. Ramachandran, S.B. Gomez, A.M. Schmidt, and C.D. Logsdon S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis Clin. Cancer Res. 18 16 2012 4356 4364 10.1158/1078-0432.ccr-12-0221
42. T. Kislinger, C. Fu, B. Huber, and et al. N(epsilon)-(carboxymethyl) lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression J. Biol. Chem. 274 44 1999 31740 31749
43. A.F. Habeeb Determination of free amino groups in proteins by trinitrobenzenesulfonic acid Anal. Biochem. 14 3 1966 328 336
44. C.M. Cuerrier, V. Chabot, S. Vigneux, and et al. Surface plasmon resonance monitoring of cell monolayer integrity: implication of signaling pathways involved in actin-driven morphological remodeling Cell Mol. Bioeng. 1 4 2008 229 239 10.1007/s12195-008-0028-4
45. V. Chabot, C.M. Cuerrier, E. Escher, V. Aimez, M. Grandbois, and P.G. Charette Biosensing based on surface plasmon resonance and living cells Biosens. Bioelectron. 24 6 2009 1667 1673 S0956-5663(08)00498-3
46. J.S. Maltais, J.B. Denault, L. Gendron, and M. Grandbois Label-free monitoring of apoptosis by surface plasmon resonance detection of morphological changes Apoptosis 2012 10.1007/s10495-012-0737-y
47. S.F. Yan, R. Ramasamy, Y. Naka, and A.M. Schmidt Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond Circ. Res. 93 12 2003 1159 1169 10.1161/01.res.0000103862.26506.3d
48. R. Wang, M. Kudo, M. Yokoyama, and G. Asano Roles of advanced glycation endproducts (AGE) and receptor for AGE on vascular smooth muscle cell growth J. Nippon Med. Sch. 68 6 2001 472 481
49. X. Ren, H. Shao, Q. Wei, Z. Sun, and N. Liu Advanced glycation end-products enhance calcification in vascular smooth muscle cells J. Int. Med. Res. 37 3 2009 847 854
50. J. Anguizola, R. Matsuda, O.S. Barnaby, and et al. Review: Glycation of human serum albumin Clin. Chim. Acta 425 2013 64 76 10.1016/j.cca.2013.07.013
51. T. Ostendorp, E. Leclerc, A. Galichet, and et al. Structural and functional insights into RAGE activation by multimeric S100B EMBO J. 26 16 2007 3868 3878 10.1038/sj.emboj.7601805
52. Z. Wang, Y. Jiang, N. Liu, and et al. Advanced glycation end-product N(-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes Atherosclerosis 221 2 2012 387 396 10.1016/j.atherosclerosis.2012.01.019
53. M. Tewari, L.T. Quan, K. O'Rourke, and et al. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase Cell 81 5 1995 801 809
54. Y.-H. Xu, J. Xiong, S.-S. Wang, D. Tang, R.-S. Wang, and Q. Zhu Calycosin entered HUVECs and ameliorated AGEs-promoted cell apoptosis via the Bcl-2 pathway J. Nat. Med. 68 1 2014 163 172 10.1007/s11418-013-0787-7
55. 2+ mediated by interleukin-8 protein J. Biol. Chem. 286 40 2011 34903 34913 10.1074/jbc.m111.279190
56. I. Tabas, and D. Ron Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress Nat. Cell Biol. 13 3 2011 184 190 10.1038/ncb0311-184
57. C. Xu, B. Bailly-Maitre, and J.C. Reed Endoplasmic reticulum stress: cell life and death decisions J. Clin. Invest. 115 10 2005 2656 2664 10.1172/jci26373
58. D.A. Chistiakov, I.A. Sobenin, A.N. Orekhov, and Y.V. Bobryshev Role of endoplasmic reticulum stress in atherosclerosis and diabetic macrovascular complications Biomed. Res. Int. 2014 2014 610140 10.1155/2014/610140
59. N.E. Cameron Role of endoplasmic reticulum stress in diabetic neuropathy Diabetes 62 3 2013 696 697 10.2337/db12-1469
60. T. Suga, T. Iso, T. Shimizu, and et al. Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells J. Atheroscler Thromb. 18 8 2011 670 683
61. T. Tanikawa, Y. Okada, R. Tanikawa, and Y. Tanaka Advance d glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MA PK J. Vasc. Res. 46 6 2009 572 580 10.1159/000226225
62. A.V. Sima, G.M. Botez, C.S. Stancu, A. Manea, M. Raicu, and M. Simionescu Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress J. Cell Mol. Med. 14 12 2010 2790 2802 10.1111/j.1582-4934.2009.00933.x
63. M.C.H. Clarke, T.D. Littlewood, N. Figg, and et al. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration Circ. Res. 102 12 2008 1529 1538 10.1161/circresaha.108.175976
64. M. San, A. artin, R. Foncea, F.R. Laurindo, R. Ebensperger, K.K. Griendling, and F. Leighton Nox1-based NADPH oxidase-derived superoxide is required for VSMC activation by advanced glycation end-products Free Radic. Biol. Med. 42 11 2007 1671 1679 10.1016/j.freeradbiomed.2007.02.002
65. J.L. Wautier, M.P. Wautier, A.M. Schmidt, and et al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications Proc. Natl. Acad. Sci. U. S. A. 91 16 1994 7742 7746
66. Z.Q. Gao, C. Yang, Y.Y. Wang, and et al. RAGE upregulation and nuclear factor-kappaB activation associated with ageing rat cardiomyocyte dysfunction Gen. Physiol. Biophys. 27 3 2008 152 158
67. B.-W. Lee, H.Y. Chae, S.J. Kwon, S.Y. Park, J. Ihm, and S.-H. Ihm RAGE ligands induce apoptotic cell death of pancreatic β-cells via oxidative stress Int. J. Mol. Med. 26 6 2010 813 818
68. C. Sun, C. Liang, Y. Ren, and et al. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways Basic Res. Cardiol. 104 1 2009 42 49 10.1007/s00395-008-0738-8
69. B. Kaltschmidt, C. Kaltschmidt, T.G. Hofmann, S.P. Hehner, W. Dröge, and M.L. Schmitz The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus Eur. J. Biochem. 267 12 2000 3828 3835
70. S.F. Yan, V. D'Agati, A.M. Schmidt, and R. Ramasamy Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging Curr. Mol. Med. 7 8 2007 699 710
71. J.C. Tóbon-Velasco, E. Cuevas, and M.A. Torres-Ramos Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress CNS Neurol. Disord. Drug Targets 13 9 2014 1615 1626
72. N. Khandelwal, J. Simpson, G. Taylor, and et al. Nucleolar NF-(B/RelA mediates apoptosis by causing cytoplasmic relocalization of nucleophosmin Cell Death Differ. 18 12 2011 1889 1903 10.1038/cdd.2011.79
73. M. Alikhani, C.M. Maclellan, M. Raptis, S. Vora, P.C. Trackman, and D.T. Graves Advance d glycation end products induce apoptosis in fibroblasts through activation of ROS, MAP kinases, and the FOXO1 transcription factor Am. J. Physiol. Cell Physiol. 292 2 2006 C850 C856 10.1152/ajpcell.00356.2006
74. D.L. Eizirik, A.K. Cardozo, and M. Cnop The role for endoplasmic reticulum stress in diabetes mellitus Endocr. Rev. 29 1 2008 42 61 10.1210/er.2007-0015
75. S.H. Back, and R.J. Kaufman Endoplasmic reticulum stress and type 2 diabetes Annu. Rev. Biochem. 81 2012 767 793 10.1146/annurev-biochem-072909-095555
76. I. Kim, W. Xu, and J.C. Reed Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities Nat. Rev. Drug Discov. 7 12 2008 1013 1030 10.1038/nrd2755
77. M. Muriach, M. Flores-Bellver, F.J. Romero, and J.M. Barcia Diabetes and the brain: oxidative stress, inflammation, and autophagy Oxid. Med. Cell. Longev. 2014 2014 102158 10.1155/2014/102158
78. L.J. Sparvero, D. Asafu-Adjei, R. Kang, and et al. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation J. Transl. Med. 7 1 2009 17 10.1186/1479-5876-7-17
79. S. Ghavami, I. Rashedi, B.M. Dattilo, and et al. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway J. Leukoc. Biol. 83 6 2008 1484 1492 10.1189/jlb.0607397
80. Q. Jin, H. Chen, A. Luo, F. Ding, and Z. Liu S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE) PLoS One 6 4 2011 e19375 10.1371/journal.pone.0019375
81. H.J. Huttunen, J. Kuja-Panula, G. Sorci, A.L. Agneletti, R. Donato, and H. Rauvala Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation J. Biol. Chem. 275 51 2000 40096 40105 10.1074/jbc.M006993200
82. J. Meloche, R. Paulin, A. Courboulin, and et al. RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes Arterioscler. Thromb. Vasc. Biol. 31 9 2011 2114 2124 10.1161/atvbaha.111.230573
83. Y. Kaji Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells Invest. Ophthalmol. Vis. Sci. 44 2 2003 521 527 10.1167/iovs. 02-0268
84. K. Han, M. Suzukawa, M. Yamaguchi, and et al. The in vitro effects of advanced glycation end products on basophil functions Int. Arch. Allergy Immunol. 155 s1 2011 64 70 10.1159/000327298
85. E. Leclerc, G. Fritz, M. Weibel, C.W. Heizmann, and A. Galichet S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains J. Biol. Chem. 282 43 2007 31317 31331 10.1074/jbc.m703951200
86. J. Xie, D.S. Burz, W. He, I.B. Bronstein, I. Lednev, and A. Shekhtman Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches J. Biol. Chem. 282 6 2007 4218 4231 10.1074/jbc.m608888200
87. R. Nagai, K. Mera, K. Nakajou, and et al. The ligand activity of AGE-proteins to scavenger receptors is dependent on their rate of modification by AGEs Biochim. Biophys. Acta - Mol. Basis Dis. 1772 11-12 2007 1192 1198 10.1016/j.bbadis.2007.09.001
88. L. Park, K.G. Raman, K.J. Lee, and et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts Nat. Med. 4 9 1998 1025 1031 10.1038/2012
89. L.G. Bucciarelli RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein e-null Mice Circulation 106 22 2002 2827 2835 10.1161/01.cir.0000039325.03698.36